It has been nearly a week that we've had time to digest the CGT Changes on ETFs. Yes, you read correct: after months of thought that any CGT changes could…
Pro Medicus Wins A$90m Beth Israel Lahey Deal
Pro Medicus (ASX:PME) has landed another major US contract, signing a seven-year, A$90m deal with Beth Israel Lahey Health, a Boston-based hospital…
Pro Medicus Secures A$80M Amid 60% Selloff
Pro Medicus (ASX:PME) jumped 4.3% on Monday after securing a A$37 million contract renewal with Northwestern Medicine at higher per-exam fees than its…
Pro Medicus jumps on new US contract
Pro Medicus (ASX:PME) jumped more than 8% on Wednesday after sealing a five-year, A$23 million contract with the University of Maryland Medical System.…
Stocks with better fundamentals trail their peers - that's just the reality of the market. But why?
What are the Best ASX Stocks to invest in right now?
Check our buy/sell…
Pro Medicus Dips Despite Strong Renewals
Pro Medicus (ASX: PME) slipped around 1% on Monday despite announcing approximately A$40m in US contract renewals, including an expanded deal with MedStar Health…
ASX healthcare stocks are crashing- which one is worth buying now?
Three of Australia's most premium ASX healthcare stocks have been crushed in the same week. CSL (ASX: CSL) has…
A Premium Multiple Leaves No Room for “Good”
Pro Medicus fell 16% despite what, on the surface, looked like an exceptional half yearly result. A lot of investors will be…
Pro Medicus slips, growth momentum remains
Pro Medicus (ASX: PME) has dropped approximately 34% from its record high of A$336 in July 2025 and now trades near A$222. Investors are…